A global forum advancing HIV/AIDS prevention, treatment innovations, public health strategies, and research toward ending the HIV epidemic.
Expert keynotes, antiretroviral therapy updates, PrEP strategies, global HIV policy discussions, stigma reduction workshops, community engagement, vaccine research, case studies, epidemiology insights & innovations in HIV diagnostics & care delivery.
1.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
2.
Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.
3.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
4.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
5.
Report provides global picture of wide inequalities in care for women's cancers
1.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
2.
Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link
3.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
4.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
5.
Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
Efficient Management of First line ALK-rearranged NSCLC - Part III
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
Recommended News For You
1.
Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.
2.
Taking vitamin D daily decreased cancer mortality, according to a study.
3.
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
4.
Oral drug combination extends progression-free survival in advanced ER-positive breast cancer
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
Conferences That Might Interest You
Recommended Articles For You
1.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
2.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
3.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
4.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
5.
Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management
Boost Your Knowledge With These Quizzes
1.
Quiz on Focal Segmental Glomerulosclerosis (FSGS) in Dialysis Patients
2.
Quiz on Tumor Heterogeneity in Cancer Vaccine Development
3.
Quiz On Bleeding And Wounds
4.
Quiz on Targeted Therapies for HER2-Positive Breast Cancer: How Well Do You Know the Latest Treatment Advances?
5.
Quiz on Innovations in Radiotherapy: How does Stereotactic Body Radiotherapy (SBRT) improve treatment efficacy?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation